HBM Partners is among the global leaders in Life Science-focused investing with over USD 1.5 billion under management. HBM’s advisory business was founded in 2001 with the vision to invest across the life cycle of healthcare companies, from venture backed early-stage all the way to listed companies.

HBM Partners manages several private-equity funds as well as cross-over and public equity funds. Our companies' teams of professionals have a thorough understanding of the biotech-medtech and diagnostics industries through active investing in both private and public companies. The teams' experts have substantial operational and financial industry experience. Since inception we have invested in over 100 companies and in most of them we actively contribute to value creation through management support and board participation.